Cargando…

Long-term Effects of Cholinesterase Inhibitors on Cognitive Decline and Mortality

OBJECTIVE: To investigate whether cholinesterase inhibitors (ChEIs) are associated with slower cognitive decline in Alzheimer dementia and decreased risk of severe dementia or death. METHODS: Patients with Alzheimer dementia from the Swedish Dementia Registry starting on ChEIs within 3 months of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Hong, Garcia-Ptacek, Sara, Jönsson, Linus, Wimo, Anders, Nordström, Peter, Eriksdotter, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166426/ https://www.ncbi.nlm.nih.gov/pubmed/33741639 http://dx.doi.org/10.1212/WNL.0000000000011832

Ejemplares similares

Controlling for selective dropout in longitudinal dementia data: Application to the SveDem registry
por: Handels, Ron, et al.
Publicado: (2020)

Effect of mortality in cost‐effectiveness modeling of disease‐modifying treatment for Alzheimer's disease
por: Aye, Sandar, et al.
Publicado: (2023)

Health-related quality of life in subjective cognitive decline and mild cognitive impairment: a longitudinal cohort analysis
por: Aye, Sandar, et al.
Publicado: (2023)

Acetyl-cholinesterase-inhibitors slow cognitive decline and decrease overall mortality in older patients with dementia
por: Zuin, Marco, et al.
Publicado: (2022)

Cholinesterase inhibitors in patients with diabetes mellitus and dementia: an open-cohort study of ~23 000 patients from the Swedish Dementia Registry
por: Secnik, Juraj, et al.
Publicado: (2020)

Association of Concomitant Use of Cholinesterase Inhibitors or Memantine With Cognitive Decline in Alzheimer Clinical Trials: A Meta-analysis
por: Kennedy, Richard E., et al.
Publicado: (2018)

Hippocampal atrophy but not white-matter changes predicts the long-term cognitive response to cholinesterase inhibitors in Alzheimer’s disease
por: Cheng, Yu-Wen, et al.
Publicado: (2015)

Suboptimal Baseline Serum Vitamin B12 Is Associated With Cognitive Decline in People With Alzheimer’s Disease Undergoing Cholinesterase Inhibitor Treatment
por: Cho, Hsiao Shan, et al.
Publicado: (2018)

The Costs of Dementia in Europe: An Updated Review and Meta-analysis
por: Jönsson, Linus, et al.
Publicado: (2022)

The Impact of Antipsychotic Drugs on Long-term Care, Nursing Home Admission, and Death in Dementia Patients
por: Nerius, Michael, et al.
Publicado: (2018)

Kidney Function, Kidney Function Decline, and the Risk of Dementia in Older Adults: A Registry-Based Study
por: Xu, Hong, et al.
Publicado: (2021)

Basal Forebrain Volume, but Not Hippocampal Volume, Is a Predictor of Global Cognitive Decline in Patients With Alzheimer's Disease Treated With Cholinesterase Inhibitors
por: Teipel, Stefan J., et al.
Publicado: (2018)

Costs of Inpatient Rehabilitation for Ischemic Stroke in Patients with Dementia: A Cohort Swedish Register-Based Study
por: Hoang, Minh Tuan, et al.
Publicado: (2020)

Progress in understanding variability in cognitive responses to cholinesterase inhibitor treatment
por: Pavlik, Valory N, et al.
Publicado: (2011)

Cholinesterase inhibitors from botanicals
por: Ahmed, Faiyaz, et al.
Publicado: (2013)

Cholinesterase inhibitors as Alzheimer's therapeutics
por: Sharma, Kamlesh
Publicado: (2019)

Proline-Based Carbamates as Cholinesterase Inhibitors †
por: Pizova, Hana, et al.
Publicado: (2017)

SveDem, the Swedish Dementia Registry – A Tool for Improving the Quality of Diagnostics, Treatment and Care of Dementia Patients in Clinical Practice
por: Religa, Dorota, et al.
Publicado: (2015)

Assessing cost-effectiveness of early intervention in Alzheimer’s disease: An open-source modeling framework
por: Green, Colin, et al.
Publicado: (2019)

Cholinesterase Inhibitors in Mild Cognitive Impairment: A Systematic Review of Randomised Trials
por: Raschetti, Roberto, et al.
Publicado: (2007)

Environmental Risks of Insecticides Cholinesterase Inhibitors
por: Mandour, Raafat A.
Publicado: (2013)

Prognostic Factors in Cholinesterase Inhibitor Poisoning
por: Sun, In O, et al.
Publicado: (2015)

Honeys as Possible Sources of Cholinesterase Inhibitors
por: Szwajgier, Dominik, et al.
Publicado: (2022)

The societal costs of dementia in Sweden 2012 – relevance and methodological challenges in valuing informal care
por: Wimo, Anders, et al.
Publicado: (2016)

Excess Mortality After COVID-19 in Swedish Long-Term Care Facilities
por: Ballin, Marcel, et al.
Publicado: (2021)

Erratum to: The societal costs of dementia in Sweden 2012 – relevance and methodological challenges in valuing informal care
por: Wimo, Anders, et al.
Publicado: (2017)

Headache related to use of cholinesterase inhibitors: study of a Cognitive Function Clinic population
por: Larner, A. J.
Publicado: (2006)

Subjective Cognitive Impairment Subjects in Our Clinical Practice
por: Garcia-Ptacek, Sara, et al.
Publicado: (2014)

Acute kidney injury and mortality risk in older adults with COVID-19
por: Xu, Hong, et al.
Publicado: (2021)

The Impact of Educational Attainment and Income on Long-Term Care for Persons with Alzheimer’s Disease and Other Dementias: A Swedish Nationwide Study
por: Hoang, Minh Tuan, et al.
Publicado: (2023)

Cholinesterase Inhibitors: Drugs Looking for a Disease?
por: Maggini, Marina, et al.
Publicado: (2006)

Structure-Based Search for New Inhibitors of Cholinesterases
por: Bajda, Marek, et al.
Publicado: (2013)

Synergism of antihypertensives and cholinesterase inhibitors in Alzheimer's disease
por: Hu, Ziheng, et al.
Publicado: (2018)

Therapeutic Potential of Multifunctional Derivatives of Cholinesterase Inhibitors
por: Przybyłowska, Maja, et al.
Publicado: (2021)

Change in cognitive function according to cholinesterase inhibitor use and amyloid PET positivity in patients with mild cognitive impairment
por: Pyun, Jung-Min, et al.
Publicado: (2021)

Prescribing cholinesterase inhibitors in mild cognitive impairment—Observations from the Alzheimer's Disease Neuroimaging Initiative
por: Stage, Eddie, et al.
Publicado: (2021)

Reexamining cholinesterase inhibitors for the prevention and treatment of delirium in high-risk populations
por: Lieberman, Ori J., et al.
Publicado: (2023)

A case report of cholinesterase inhibitor poisoning: cholinesterase activities and analytical methods for diagnosis and clinical decision making
por: Amend, N., et al.
Publicado: (2020)

Association Between Cognition, Health Related Quality of Life, and Costs in a Population at Risk for Cognitive Decline
por: Janssen, Niels, et al.
Publicado: (2022)

Can cochlear implantation prevent cognitive decline in the long-term follow-up?
por: Völter, Christiane, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m47gga2u3uojnf3k4ujcnbunqt